Drug shortage
Methylprednisolone Acetate Injection · Par Pharmaceutical, Inc.
FDA drug shortage · Current · updated May 8, 2026
Key facts
| Generic name | Methylprednisolone Acetate Injection |
|---|---|
| Company | Par Pharmaceutical, Inc. |
| Presentation | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) |
| Dosage form | Injection |
| Status | Current |
| Reason for shortage | Shortage of an active ingredient |
| Therapeutic category | Rheumatology |
| Package NDCs | 42023-240-01 |
| First posted | Jun 16, 2022 |
| Last updated | May 8, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: